| scholarly article | Q13442814 |
| P2093 | author name string | Rogers L | |
| Kolattukudy PE | |||
| Quach T | |||
| Breckenridge S | |||
| Chakravarty L | |||
| P2860 | cites work | A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions | Q24597783 |
| Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution | Q27731946 | ||
| The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions | Q27734322 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 | ||
| Chemokines and leukocyte traffic | Q29618886 | ||
| Refinement of the structure of human basic fibroblast growth factor at 1.6 Å resolution and analysis of presumed heparin binding sites by selenate substitution | Q30194894 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer | Q34219670 | ||
| The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand | Q34438280 | ||
| Structure of human monocyte chemotactic protein gene and its regulation by TPA. | Q34661435 | ||
| Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis | Q35821357 | ||
| Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia | Q35980114 | ||
| Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts | Q36393456 | ||
| Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. | Q36453167 | ||
| Proteoglycans: structures and interactions | Q37285263 | ||
| Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 | ||
| Initiating events of acute coronary arterial occlusion | Q37722998 | ||
| Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity | Q38362797 | ||
| Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. | Q40893812 | ||
| The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation | Q41175846 | ||
| Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1 | Q41851917 | ||
| Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding | Q42002922 | ||
| Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. | Q55482583 | ||
| Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines | Q57019212 | ||
| T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ | Q59068529 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 29641-29647 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding | |
| P478 | volume | 273 |
| Q38008721 | A beginner's guide to chemokines |
| Q41908191 | Affinity-based microdialysis sampling using heparin for in vitro collection of human cytokines |
| Q28574502 | Blocking of monocyte chemoattractant protein-1 during tubulointerstitial nephritis resulted in delayed neutrophil clearance |
| Q34528303 | Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs |
| Q40261698 | CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation |
| Q40721527 | Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC. |
| Q35611323 | Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2. |
| Q38194193 | Demystifying heparan sulfate-protein interactions. |
| Q27649259 | Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor |
| Q40612700 | Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration |
| Q92513107 | Factors Associated with RANTES Concentration in Cardiovascular Disease Patients |
| Q34762409 | Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q38343397 | Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. |
| Q35067418 | Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II |
| Q80067132 | Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65-76 of monocyte chemotactic protein-1 (MCP-1) |
| Q34065898 | Monocyte-mediated defense against microbial pathogens. |
| Q40044234 | Perlecan: a major IL-2-binding proteoglycan in murine spleen |
| Q54518682 | Rapid site-directed mutagenesis of chemokines and their purification from a bacterial expression system. |
| Q36631409 | Soluble mimics of a chemokine receptor: Chemokine binding by receptor elements juxtaposed on a soluble scaffold |
| Q27627808 | Solution structure and dynamics of myeloid progenitor inhibitory factor-1 (MPIF-1), a novel monomeric CC chemokine |
| Q51207653 | Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody. |
| Q33370024 | Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis |
| Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
| Q91973506 | Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation |
| Q28140341 | The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity |
| Q36371175 | The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis |
| Q38361416 | The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides |
| Q27622258 | The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement |
| Q51590709 | The structural investigation of glycosaminoglycan binding to CXCL12 displays distinct interaction sites. |
| Q38678399 | The sweet spot: how GAGs help chemokines guide migrating cells |
| Q43734001 | The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site |
Search more.